Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

about

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

Item

http://www.wikidata.org/entity/Q49390262

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

@en

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

@nl

type

Item

label

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

@en

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

@nl

prefLabel

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

@en

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

@nl

P1476

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

@en

P2093

Camilla Holmlund

http://www.w3.org/2001/XMLSchema#string

Feng Mao

http://www.w3.org/2001/XMLSchema#string

Håkan Hedman

http://www.w3.org/2001/XMLSchema#string

Mahmood Faraz

http://www.w3.org/2001/XMLSchema#string

Mikael Johansson

http://www.w3.org/2001/XMLSchema#string

Roger Henriksson

http://www.w3.org/2001/XMLSchema#string

Samuel Kvarnbrink

http://www.w3.org/2001/XMLSchema#string

Tommy Bergenheim

http://www.w3.org/2001/XMLSchema#string

Wanzhong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence

LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

Lrig2-deficient mice are protected against PDGFB-induced glioma

Characterization and tissue-specific expression of human LRIG2.

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

P2888

s41389-017-0012-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41389-017-0012-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100737795

http://www.w3.org/2001/XMLSchema#string

P698

29391393

http://www.w3.org/2001/XMLSchema#string

P921

haploinsufficiency

P932

5833707

http://www.w3.org/2001/XMLSchema#string